Results 61 to 70 of about 191,742 (248)
Platelet-Derived Growth Factor-Receptor α Strongly Inhibits Melanoma Growth In Vitro and In Vivo
Cutaneous melanoma is the most aggressive skin cancer; it is highly metastatic and responds poorly to current therapies. The expression of platelet-derived growth factor receptors (PDGF-Rs) is reported to be reduced in metastatic melanoma compared with ...
Debora Faraone+11 more
doaj +1 more source
Platelet-derived growth factor receptor-β antagonism restores morphine analgesic potency against neuropathic pain. [PDF]
Chronic, intractable pain is a problem of pandemic proportions. Pain caused by nerve injuries (neuropathic pain) is extremely difficult to treat. For centuries, opiates such as morphine have been the first-line treatment for severe chronic pain. However,
Courtney L Donica+3 more
doaj +1 more source
Signaling cascades elicited by angiotensin II resemble those characteristic of growth factor stimulation. In this report, we demonstrate that angiotensin II converges with platelet-derived growth factor (PDGF) β-receptor signaling cascades, independent ...
D. Linseman+2 more
semanticscholar +1 more source
Platelet-derived growth factor receptors in the kidney—Upregulated expression in inflammation
Major features of a long-standing inflammation in the kidney are vascular proliferation, glomerulosclerosis, interstitial fibrosis and tubular atrophy, leading to a gradual deterioration of the renal function. In this study we have investigated the expression of B-type receptors for platelet-derived growth factor (PDGF) in frozen sections from normal ...
Gunnar Tufveson+8 more
openaire +3 more sources
Integrin-mediated cell attachment and growth factor stimulation often act synergistically on cell proliferation, differentiation, migration, and survival.
E. Borges, Y. Jan, E. Ruoslahti
semanticscholar +1 more source
Purpose: Platelet-derived growth factor receptor-alpha (PDGFRA) mutations are found in approximately 5% to 7% of advanced gastrointestinal stromal tumors (GIST). We sought to extensively assess the activity of imatinib in this subgroup.
P. Cassier+19 more
semanticscholar +1 more source
The Cbl proto-oncogene product has emerged as a novel negative regulator of receptor and non-receptor tyrosine kinases. Our previous observations that Cbl overexpression in NIH3T3 cells enhanced the ubiquitination and degradation of the platelet-derived ...
S. Miyake+4 more
semanticscholar +1 more source
Pazopanib for the treatment of soft-tissue sarcoma
Pierre Heudel,1 Philippe Cassier,1 Olfa Derbel,1 Armelle Dufresne,1 Pierre Meeus,2 Philippe Thiesse,3 Dominique Ranchère-Vince,4 Jean Yves Blay,1 Isabelle Ray-Coquard1,51Department of Medical Oncology, 2Department of Surgical Oncology ...
Heudel P+8 more
doaj
Primary familial brain calcification (PFBC) is a rare genetic neurodegenerative disorder characterized by bilateral calcifications in the brain. PFBC may manifest with a broad spectrum of motor, cognitive, and neuropsychiatric symptoms.
Conghui Cao+3 more
doaj +1 more source
6-Methoxy-2-methyl-1-m-tolyl-1H-benzimidazole hemihydrate
The title compound, C16H16N2O·0.5H2O, is a substituted 1-phenylbenzimidazole, which belongs to the class of ATP-site inhibitors of the platelet-derived growth-factor receptor.
Xu-Bin Fang, Lei Fang, Xu-Ying Liu
doaj +1 more source